Besides, Erianin synergizes with 5-fluorouracil to inhibit the LKB1-SIK2/3-PARD3 pathway in gastric cancer, reversing the expression of EMT-related proteins (Wei et al., 2024). Here, PARD3 is linked to gastric cancer.